Trulieve Cannabis Corp. (OTCMKTS:TCNNF) Short Interest Down 13.7% in June

Trulieve Cannabis Corp. (OTCMKTS:TCNNFGet Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 644,400 shares, a decrease of 13.7% from the May 31st total of 746,600 shares. Based on an average daily trading volume, of 781,600 shares, the days-to-cover ratio is currently 0.8 days.

Trulieve Cannabis Price Performance

Shares of TCNNF opened at $9.29 on Tuesday. The company’s 50-day moving average is $10.42 and its 200-day moving average is $9.56. Trulieve Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $14.50.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on TCNNF shares. Roth Mkm boosted their price objective on shares of Trulieve Cannabis from $16.00 to $19.00 and gave the company a “buy” rating in a report on Friday, May 10th. Needham & Company LLC raised their price objective on Trulieve Cannabis from $13.50 to $14.50 and gave the company a “buy” rating in a report on Friday, May 10th.

Check Out Our Latest Analysis on TCNNF

Trulieve Cannabis Company Profile

(Get Free Report)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands.

See Also

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.